Our story started in 2008
Ecclis is founded in 2024. Althoug we are a young company, our dna goes back to 2008 when Jalmar Wesselink started the “Pharma Results” company. This company focussed on Rx to OTC switches and provided services to major global Pharmaceutical companies like Pfizer, Johnson & Johnson, Galderma, Sandoz, Sprig Pharma, Grünenthal and Boehringer Ingelheim. Besides Rx to OTC switches, the activities where also extended to Brand & Business Development, Commercial Excellence Training. For retailers like Ahold, the compancy provided GDP (Good Distribution Practices) and RP (Responsible Person) services by secondment of Industrial Pharmacist to enable the distribution and sales of pharmaceutical products.
In 2021 Jalmar Wesselink stopped the “Pharma Results” activities to join the Pharmaceutical company Boehringer Ingelheim GmbH in a Global role at their Headquaters in Germany. During the Covid period, the online sales became extreamely important and global E-Retailers like Amazon are an essential player in the Route to Market.
In November 2024 Jalmar Wesselink return to the Netherlands to continue the Pharma Results activities under a new name. The Ecclis company was born!
The Ecclis mission is to provide FMCG, Consumer Health & Animal Health companies with advice and support in the fields of Marketing, Sales, E-Retail and Rx to OTC switches.
ECCLIS B.V.
is a company registered in The Netherlands under Chamber of Commerce number 95388788
Phone nr. :
+31 (0)6 820 975 07
VAT registration nr. :
NL867111367B01
Bankaccount nr. :
NL89 INGB 0109 9596 55
Trade Names
Ecclis B.V. is opperating under the following trade names: Ecclis, Pharma Results, Brand Potential Monitor and Narumi
OUR TEAM PROUDLY WORKED FOR
Including the projects completed under the Pharma Results banner